A balanced approach to diet, exercise, and hormone therapy is often the most effective strategy for achieving long-term health and fitness goals
An 8-week randomized double-blind trial comparing GHK-Cu in nano-lipid carriers showed 55.8% reduction in wrinkle volume versus control serum
GLP-1s can cost patients $12,000 per year out-of-pocket if not covered by their insurance provider, with spending on GLP-1s increasing more than 500% in the US between 2018 and 2023
For many people with diabetes, managing weight is an important aspect of controlling the disease
Glucagon-like peptide-1 (GLP-1) agonists are injectable weight loss drugs that help people feel fuller and eat less food, leading to weight loss
This strategy has been exploited in the long-acting GLP-1RA semaglutide (Novo Nordisk), for instance, which was approved for treatment of T2DM in 2017, and for treatment of obesity in 2021, and has since then become the most prescribed GLP-1RA 92